Sikic BI - Search Results

1

Dissociation of antitumor potency from anthracycline cardiotoxicity in a doxorubicin analog.

Sikic BI, Ehsan MN, Harker WG, Friend NF, Brown BW, Newman RA, Hacker MP, Acton EM. Sikic BI, et al. Science. 1985 Jun 28;228(4707):1544-6. doi: 10.1126/science.4012308. Science. 1985. PMID: 4012308

2

Verapamil-mediated sensitization of doxorubicin-selected pleiotropic resistance in human sarcoma cells: selectivity for drugs which produce DNA scission.

Harker WG, Bauer D, Etiz BB, Newman RA, Sikic BI. Harker WG, et al. Among authors: sikic bi. Cancer Res. 1986 May;46(5):2369-73. Cancer Res. 1986. PMID: 3754487

3

Multidrug (pleiotropic) resistance in doxorubicin-selected variants of the human sarcoma cell line MES-SA.

Harker WG, Sikic BI. Harker WG, et al. Among authors: sikic bi. Cancer Res. 1985 Sep;45(9):4091-6. Cancer Res. 1985. PMID: 4028002

4

Multifactorial mechanisms associated with broad cross-resistance of ovarian carcinoma cells selected by cyanomorpholino doxorubicin.

Lau DH, Lewis AD, Ehsan MN, Sikic BI. Lau DH, et al. Among authors: sikic bi. Cancer Res. 1991 Oct 1;51(19):5181-7. Cancer Res. 1991. PMID: 1717140

5

Development and characterization of a human sarcoma cell line, MES-SA, sensitive to multiple drugs.

Harker WG, MacKintosh FR, Sikic BI. Harker WG, et al. Among authors: sikic bi. Cancer Res. 1983 Oct;43(10):4943-50. Cancer Res. 1983. PMID: 6883344

6

Phase I trial of doxorubicin with cyclosporine as a modulator of multidrug resistance.

Bartlett NL, Lum BL, Fisher GA, Brophy NA, Ehsan MN, Halsey J, Sikic BI. Bartlett NL, et al. Among authors: sikic bi. J Clin Oncol. 1994 Apr;12(4):835-42. doi: 10.1200/JCO.1994.12.4.835. J Clin Oncol. 1994. PMID: 8151326 Clinical Trial.

7

High-dose megestrol acetate therapy of ovarian carcinoma: a phase II study by the Northern California Oncology Group.

Sikic BI, Scudder SA, Ballon SC, Soriero OM, Christman JE, Suey L, Ehsan MN, Brandt AE, Evans TL. Sikic BI, et al. Semin Oncol. 1986 Dec;13(4 Suppl 4):26-32. Semin Oncol. 1986. PMID: 3099393

8

In vitro selection and characterization of a bleomycin-resistant subline of B16 melanoma.

Zuckerman JE, Raffin TA, Brown JM, Newman RA, Etiz BB, Sikic BI. Zuckerman JE, et al. Among authors: sikic bi. Cancer Res. 1986 Apr;46(4 Pt 1):1748-53. Cancer Res. 1986. PMID: 2418953

9

Alteration of etoposide pharmacokinetics and pharmacodynamics by cyclosporine in a phase I trial to modulate multidrug resistance.

Lum BL, Kaubisch S, Yahanda AM, Adler KM, Jew L, Ehsan MN, Brophy NA, Halsey J, Gosland MP, Sikic BI. Lum BL, et al. Among authors: sikic bi. J Clin Oncol. 1992 Oct;10(10):1635-42. doi: 10.1200/JCO.1992.10.10.1635. J Clin Oncol. 1992. PMID: 1403041 Clinical Trial.

10

Expression of multidrug resistance gene mdr1 mRNA in a subset of normal bone marrow cells.

Marie JP, Brophy NA, Ehsan MN, Aihara Y, Mohamed NA, Cornbleet J, Chao NJ, Sikic BI. Marie JP, et al. Among authors: sikic bi. Br J Haematol. 1992 Jun;81(2):145-52. doi: 10.1111/j.1365-2141.1992.tb08199.x. Br J Haematol. 1992. PMID: 1353683

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

207 results

Search Page

Filters